Difference in imipenem, meropenem, sulbactam, and colistin nonsusceptibility trends among three phenotypically undifferentiated Acinetobacter baumannii complex in a medical center in Taiwan, 1997-2007

Journal of Microbiology, Immunology and Infection

Volumn 44, Issue 5, 2011, Pages 358-363

  Liang Yu, Chen ^a   Kuo, Shu Chen ^a   Liu, Chun Yu ^a,b   Luo, Bin Syun ^b   Huang, Ling Ju ^a,b   Lee, Yi Tzu ^b,c   Chen, Chien Pei ^a   Chen, Te Li ^a,b   Fung, Chang Phone ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c Chutung Veterans General Hospital   (Taiwan)

Author keywords

Acinetobacter baumannii complex; Antimicrobial susceptibility; Resistance; Trend

Indexed keywords

COLISTIN; IMIPENEM; MEROPENEM; SPACER DNA; SULBACTAM;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; AGAR DILUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL GENOME; BACTERIUM ISOLATE; MINIMUM INHIBITORY CONCENTRATION; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PHENOTYPE; SEQUENCE ANALYSIS; SPECIES DIFFERENCE; SPECIES IDENTIFICATION; TAIWAN; TREND STUDY;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAMS; CLUSTER ANALYSIS; COLISTIN; DRUG RESISTANCE, BACTERIAL; ENZYME INHIBITORS; GENOTYPE; HOSPITALS, VETERANS; HUMANS; MICROBIAL SENSITIVITY TESTS; MULTIPLEX POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SULBACTAM; TAIWAN;

EID: 80053639468     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2011.01.032     Document Type: Article

References (23)

1. Peleg A.Y., Seifert H., Paterson D.L. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008 Jul, 21:538-582.
2. Dijkshoorn L., Nemec A., Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 2007 Dec, 5:939-951.
3. Karageorgopoulos D.E., Falagas M.E. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis 2008 Dec, 8:751-762.
4. Perez F., Hujer A.M., Hujer K.M., Decker B.K., Rather P.N., Bonomo R.A. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2007 Oct, 51:3471-3484.
5. Munoz-Price L.S., Weinstein R.A. Acinetobacter infection. N Engl J Med 2008 Mar 20, 358:1271-1281.
6. Duenas Diez A.I., Bratos Perez M.A., Eiros Bouza J.M., Almaraz Gomez A., Gutierrez Rodriguez P., Miguel Gomez M.A., et al. Susceptibility of the Acinetobacter calcoaceticus-A. baumannii complex to imipenem, meropenem, sulbactam and colistin. Int J Antimicrob Agents 2004, 23:487-493.
7. Ko W.C., Lee N.Y., Su S.C., Dijkshoorn L., Vaneechoutte M., Wang L.R., et al. Oligonucleotide array-based identification of species in the Acinetobacter calcoaceticus-A. baumannii complex in isolates from blood cultures and antimicrobial susceptibility testing of the isolates. J Clin Microbiol 2008, 46:2052-2059.
8. Lee J.H., Choi C.H., Kang H.Y., Lee J.Y., Kim J., Lee Y.C., et al. Differences in phenotypic and genotypic traits against antimicrobial agents between Acinetobacter baumannii and Acinetobacter genomic species 13TU. J Antimicrob Chemother 2007, 59:633-639.
9. Lee Y.T., Huang L.Y., Chiang D.H., Chen C.P., Chen T.L., Wang F.D., et al. Differences in phenotypic and genotypic characteristics among imipenem-non-susceptible Acinetobacter isolates belonging to different genomic species in Taiwan. Int J Antimicrob Agents 2009, 34:580-584.
10. Lim Y.M., Shin K.S., Kim J. Distinct antimicrobial resistance patterns and antimicrobial resistance-harboring genes according to genomic species of Acinetobacter isolates. J Clin Microbiol 2007 Mar, 45:902-905.
11. Chen C.M., Liu P.Y., Ke S.C., Wu H.J., Wu L.T. Investigation of carbapenem-resistant Acinetobacter baumannii isolates in a district hospital in Taiwan. Diagn Microbiol Infect Dis 2009 Apr, 63:394-397.
12. Kuo H.Y., Yang C.M., Lin M.F., Cheng W.L., Tien N., Liou M.L. Distribution of blaOXA-carrying imipenem-resistant Acinetobacter spp. in 3 hospitals in Taiwan. Diagn Microbiol Infect Dis 2010 Feb, 66:195-199.
13. Poirel L., Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 2006, 12:826-836.
14. Chen T.L., Siu L.K., Wu R.C., Shaio M.F., Huang L.Y., Fung C.P., et al. Comparison of one-tube multiplex PCR, automated ribotyping and intergenic spacer (ITS) sequencing for rapid identification of Acinetobacter baumannii. Clin Microbiol Infect 2007 Aug, 13:801-806.
15. Chang H.C., Wei Y.F., Dijkshoorn L., Vaneechoutte M., Tang C.T., Chang T.C. Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region. J Clin Microbiol 2005 Apr, 43:1632-1639.
16. CLSI Performance standards for antimicrobial susceptibility testing: twentieth informational supplement 2010, CLSI document M100-S20, Clinical and Laboratory Standards Institute, Wayne (PA).
17. Lu P.L., Huang L.Y., Lian S.T., Chang K., Lin C.L., Hwang I.J., et al. How carbapenem-resistant Acinetobacter spp. established in a newly constructed hospital. Int J Antimicrob Agents 2008 May, 31:463-466.
18. Monterrubio-Villar J., Gonzalez-Velasco C., Valdezate-Ramos S., Cordoba-Lopez A., Villalon-Panzano P., Saez-Nieto J.A. Outbreak of multiresistant Acinetobacter baumannii in a polyvalent intensive care unit: clinical, epidemiological analysis and PFGE-printing evolution. Eur J Clin Microbiol Infect Dis 2009 Oct, 28:1281-1284.
19. Perez F., Endimiani A., Ray A.J., Decker B.K., Wallace C.J., Hujer K.M., et al. Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination. J Antimicrob Chemother 2010 Aug, 65:1807-1818.
20. Lu P.L., Siu L.K., Chen T.C., Ma L., Chiang W.G., Chen Y.H., et al. Methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii on computer interface surfaces of hospital wards and association with clinical isolates. BMC Infect Dis 2009, 9:164.
21. Boo T.W., Walsh F., Crowley B. Molecular characterization of carbapenem-resistant Acinetobacter species in an Irish university hospital: predominance of Acinetobacter genomic species 3. J Med Microbiol 2009 Feb, 58:209-216.
22. Nemec A., Dijkshoorn L. Variations in colistin susceptibility among different species of the genus Acinetobacter. J Antimicrob Chemother 2010, 65:367-369.
23. Smolyakov R., Borer A., Riesenberg K., Schlaeffer F., Alkan M., Porath A., et al. Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment. J Hosp Infect 2003 May, 54:32-38.